HSBC Holdings’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $141K | Sell |
10,048
-47,955
| -83% | -$674K | ﹤0.01% | 2310 |
|
|
2025
Q1 | $779K | Buy |
58,003
+24,613
| +74% | +$330K | ﹤0.01% | 1451 |
|
|
2024
Q4 | $680K | Buy |
33,390
+6,507
| +24% | +$133K | ﹤0.01% | 1626 |
|
|
2024
Q3 | $779K | Sell |
26,883
-2,759
| -9% | -$80K | ﹤0.01% | 1461 |
|
|
2024
Q2 | $668K | Buy |
29,642
+13,454
| +83% | +$303K | ﹤0.01% | 1519 |
|
|
2024
Q1 | $332K | Sell |
16,188
-704
| -4% | -$14.4K | ﹤0.01% | 1973 |
|
|
2023
Q4 | $364K | Sell |
16,892
-535
| -3% | -$11.5K | ﹤0.01% | 1752 |
|
|
2023
Q3 | $359K | Buy |
+17,427
| New | +$359K | ﹤0.01% | 1653 |
|
|
2023
Q2 | – | Sell |
-13,553
| Closed | -$311K | – | 2143 |
|
|
2023
Q1 | $311K | Buy |
13,553
+4,204
| +45% | +$96.4K | ﹤0.01% | 1802 |
|
|
2022
Q4 | $256K | Buy |
9,349
+1,675
| +22% | +$45.8K | ﹤0.01% | 2180 |
|
|
2022
Q3 | $239K | Buy |
+7,674
| New | +$239K | ﹤0.01% | 2101 |
|